Moskowitz, Milton

The only pharmaceutical company to rate as one of Fortune s 100 Best Companies to Work For every year since the list started in 1998, and the only pharmaceutical company to qualify for the precursor list, initiated by veteran business writer Milton Moskowitz in 1984, for every year of its existence but one. 

And the cost-cutting and uncertainty that inevitably accompany a merger can hurt staff morale as people await the ax. Milton Moskowitz, the pioneer in ranking best places to work, says one reason Merck keeps placing so high on these lists is that it has adamantly refused to merge. People feel, if they do well, they ll move up. They won t be displaced by someone from another company, he notes. 

W. R. Grace s experience as a conglomerate to the end of the 1980s is summarized in Derdak, ed.. International Directory, vol. 1 (1988), pp. 547-549, supplemented by Milton Moskowitz, Robert Levering, and Michael Katz, Everybody s Business A Field Guide to the 400 Leading Companies in America (New York Doubleday Currency, 1990), pp. 529-530. 

Pratt, Pfizer, pp. 11-14 Temin, Taking Your Medicine, pp. 66, 69-74. McKeen s aggressive strategy is well defined in Milton Moskowitz, Michael Katz, and Robert Levering, Everybody s Business An Almanac (San Francisco Harper Row, 1980) Derdak, ed., International Directory, vol. 9, p. 403. 

---